Design and Investigation of Core/Shell GQDs/hMSN Nanoparticles as an Enhanced Drug Delivery Platform in Triple-Negative Breast Cancer

Bioconjugate Chemistry
Dongzhi YangHao Hong

Abstract

Due to the excellent photoluminescent properties and singlet oxygen (1O2) generating efficiency, graphene quantum dots (GQDs) with maximal emission in near-infrared region (NIR) exhibited great potential in cancer imaging and therapy. However, GQDs can be cleared quickly via the renal system in vivo because of their ultrasmall size, which leads to the compromised cancer cell killing efficacy. Here, we report a hybrid nanoplatform, where GQDs were incorporated into the cavity of hollow mesoporous silica nanoparticles (hMSN) to form GQDs@hMSN-PEG nanoparticles (NPs). Optical characterization indicated that GQDs@hMSN-PEG NPs still maintained good absorption and emission properties from GQDs, and the composite NPs still possessed similar 1O2 generating efficiency. GQDs@hMSN-PEG NPs exhibited good biocompatibility in vitro and in vivo. High cargo-loading efficiency was achieved for doxorubicin (DOX), and the formed GQDs@hMSN(DOX)-PEG NPs showed the feasibility of tumor-oriented drug delivery. The extended retention time in tumor and good drug loading efficacy confirmed that GQDs@hMSN-PEG could serve as one promising candidate for combinational cancer treatment where photodynamic therapy and chemotherapy modules can be integrated int...Continue Reading

References

Oct 20, 2004·Nitric Oxide : Biology and Chemistry·Snezana M MirkovRadmila Z Kovacevic
Jun 16, 2005·Bioorganic & Medicinal Chemistry·Stanislav JaraczIwao Ojima
Sep 22, 2010·Journal of the American Chemical Society·Jian ZhangChad A Mirkin
Oct 23, 2010·Advanced Drug Delivery Reviews·Sarbari Acharya, Sanjeeb K Sahoo
Jul 17, 2012·Biomaterials·Zoran M MarkovicVladimir S Trajkovic
Sep 26, 2013·Nature Reviews. Cancer·Caitriona HolohanPatrick G Johnston
Aug 12, 2014·Nature Communications·Jiechao GeXiaodong Han
Dec 28, 2009·Advanced Materials·Xiaohua HuangMostafa A El-Sayed
Jul 8, 2015·ACS Nano·Mengxiao Yu, Jie Zheng
Oct 23, 2015·International Journal of Nanomedicine·Guomu LiuGuixiang Tai
May 24, 2017·International Journal of Nanomedicine·Meng-Meng LuYan-Min Zhou
Jul 25, 2017·Nanomaterials·Anna Watermann, Juergen Brieger

❮ Previous
Next ❯

Citations

Jul 2, 2020·Advanced Drug Delivery Reviews·David C LutherVincent M Rotello
May 9, 2021·International Journal of Pharmaceutics·JinLing ZhengHongFei Chen
Jul 17, 2021·Journal of Nanobiotechnology·Guangman CuiGuangyu Yao
Feb 1, 2020·Current Medicinal Chemistry·Elzbieta Pedziwiatr-WerbickaMaria Bryszewska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.